Moneycontrol PRO
HomeNewsTechnologyMyJio Coronavirus Self-diagnostic Tool: Check your risk level for COVID-19

MyJio Coronavirus Self-diagnostic Tool: Check your risk level for COVID-19

The MyJio Coronavirus Self-diagnostic Tool will provide a simple and accessible national platform for citizens to declare their health parameters, and be guided to scientifically recommended next-steps based on their risk-status.

March 24, 2020 / 19:31 IST


Reliance Jio has launched a new nation-wide tool called MyJio Coronavirus Self-diagnostic Tool for all Indian citizens.

The tool aims at assisting the government’s measures to contain and mitigate the impact of coronavirus in several ways. The MyJio Coronavirus Self-diagnostic Tool will provide a simple and accessible national platform for citizens to declare their health parameters, and be guided to scientifically recommended next-steps based on their risk-status. There are three such risk-factors — Low Risk, Moderate Risk, High Risk.

For Low-risk citizens, the MyJio Coronavirus Self-diagnostic Tool will put to rest any possible misapprehensions, as well as reinforce social isolation messages. The tool will inform medium risk citizens about their prognosis and will also guide them with key information like what to watch out for and where to seek help if they need medical assistance.

For high-risk citizens, the MyJio Coronavirus Self-diagnostic Tool can channelise them to appropriate medical interventions so that they are isolated and treated promptly.

Further, the back-end data being captured by this national platform can serve as a powerful information source that can give visibility to policymakers and administration officials about the emerging situation on the ground.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The tool also aims at having periodic push-campaigns to check-in with citizens about any change in their health situation, and reassess risk and subsequent actions.

All these features can be accessed via the MyJio app on any smartphone. Reliance Jio has gone a step ahead and opened the MyJio app even to non-Jio customers. This means that customers using Airtel, Vodafone-Idea, and other telecom services can also download the MyJio app and gain access to this self-diagnosis tool, without any restriction or cost.

MyJio Coronavirus Self-diagnostic Tool is currently available in English and will offer support for Hindi and other Indian languages within the next 24-48 hours.

Disclaimer: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.

Invite your friends and family to sign up for MC Tech 3, our daily newsletter that breaks down the biggest tech and startup stories of the day

Moneycontrol News
first published: Mar 24, 2020 10:20 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347